Patients with ataxia telangiectasia (A-T), carrying mutations at both ataxia telangiectasia mutated (ATM) alleles (ATM−/−), present with progressive cerebellar ataxia, susceptibility to cancer, immunodeficiency, insulin resistance and hyperglycemia (1,2). This evidence concerns the gene ATM and immune system disorder.